Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low-dose bupivacaine with EVE for short obstetric procedures
NCT03110003Phase 3Completed
- Sponsor
- University of Alabama at Birmingham
- Start
- Jun 2016
- Primary completion
- Dec 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of bupivacaine (2 arms), sponsored by University of Alabama at Birmingham. Primary endpoint: Time Until Post-Anesthesia Care Unit Discharge at 48 hours. Started Jun 2016; status: completed.
02
Drugs
bupivacaine
Beyond the preview
Go deeper on NCT03110003.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03110003.